We will discuss Labour induction near term for women aged 35 or over: an economic evaluation by Walker and coauthors on the 29th March 2017. This paper is free to view from 20th March. Start date: 29 March 2017. The discussion will continue for … Continue reading
For next #BlueJC on the 22nd February we will discuss the use of cranberry capsules after pelvic surgery to prevent bacteriuria. Continue reading
We will discuss Double-balloon catheter versus prostaglandin E2 for cervical ripening and labour induction by Du and co-authors on the 25th January for 7 days.
Start date: 25 January 2017 (the discussion will continue for 7 days between 25th January and 1st February 2017.
First hosted discussion session(s) on Twitter starts at GMT 8pm (3pm EST/12 noon PST) on 25 January 2017 (using hashtag #BlueJC).
The Blue Journal Club is an international journal club on women’s health research based on Twitter (as @BlueJCHost). We start our conversation on the last Wednesday of every month and use the hashtag #BlueJC for our tweets. Simply add this hashtag (“#BlueJC”) to each tweet and we will capture it. Each #BlueJC opens for 7 days with an advertised start time. All BJOG #BlueJC papers also have complementary slide sets suitable for face-to-face journal clubs with your local colleagues.
The discussion points are attached below:
A 26 year old woman in her first pregnancy requires induction of labour at term for reduced fetal movements. She has a normal CTG, normal scan with normal umbilical artery Doppler studies, and no other risk factors.
What method of induction of labour would you recommend?
Description of Research:
|Participants||Women with singleton pregnancies with live fetuses in vertex presentation, intact membranes, and unfavourable cervices, requiring induction of labour.|
|Intervention||Transcervical double balloon catheter|
|Comparison||Locally applied prostaglandin E2 analogues|
|Outcomes||Primary: (1) proportion of women achieving vaginal delivery within 24 hours, (2) proportion of women delivering by Caesarean
Secondary: (1) Uterine hyperstimulation; (2) Neonatal unit admission; (3) Maternal adverse events (PPH, uterine rupture).
|Study design||Metanalysis of randomised controlled trials
- How do you currently counsel women similar to the one in the scenario?
- Have you used double-balloon catheters? Do you find that they are well tolerated?
- How did the authors assess the quality of individual studies?
- What were the problems identified by their quality assessment of individual studies?
- Critically appraise this meta-analysis using the PRISMA checklist (http://prisma-statement.org/PRISMAStatement/Checklist.aspx)
- Can you briefly summarise the results of this study as a one-sentence take-home message?
- Would the results of this study influence your management of the woman in the scenario?
- How would the results of this study influence your daily practice?
Scottish Intercollegiate Guidelines Network. Critical Appraisal: notes and checklists. Methodology checklist 1: Systematic reviews and meta-analyses. http://www.sign.ac.uk/methodology/checklists.html (Last access 20 July 2016)
Pre-menopausal women with heavy periods or inter-menstrual bleeding often have biopsies performed. Is it really indicated? Discuss at #BlueJC in November 2016. Continue reading
Lymph node assessment in ovarian cancer can lead to significant morbidity. Results of this systematic review suggests < 1 in 100 (0.8%) women with stage 1-2 mucinous ovarian cancer undergoing lymph node assessment had metastases in resected lymph nodes.
Is it time to change practice?
Global economic turnmoils, disasters and conflicts have markedly increased the number of migrants and refugees from low-and-middle income countries (LMICs). This #BlueJC explores how we could improve care for pregnant and post-partum migrants. Continue reading
Syphilis screening is routinely offered at the first antenatal visit. Does the resource spent influence on the future health of mothers and babies? Continue reading
Women presented with post-menopausal bleeding and normal blind biopsy. Is that enough to reassure the doctor and patient involved? Continue reading
Can we justify the under-representation of pregnant women in clinical trials? Are we failing pregnant women by excluding them from drug trials? Discuss the dilemma at the next #BlueJC Continue reading
Is paternal depression a significant risk factor of preterm birth? Join this #BlueJC to find out more. Continue reading